| 000 | 01900 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250516114027.0 | ||
| 264 | 0 | _c20130322 | |
| 008 | 201303s 0 0 eng d | ||
| 022 | _a1423-0240 | ||
| 024 | 7 |
_a10.1159/000342674 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKaya, Ali O | |
| 245 | 0 | 0 |
_aPaclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy. _h[electronic resource] |
| 260 |
_bOnkologie _c2012 |
||
| 300 |
_a576-80 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdiagnosis |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatinum _xadministration & dosage |
| 650 | 0 | 4 |
_aPremedication _xmethods |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aCoskun, Ugur | |
| 700 | 1 | _aOzkan, Metin | |
| 700 | 1 | _aSevinc, Alper | |
| 700 | 1 | _aYilmaz, Ahmet U | |
| 700 | 1 | _aGumus, Mahmut | |
| 700 | 1 | _aUnal, Olcun U | |
| 700 | 1 | _aOzdemir, Nuriye Y | |
| 700 | 1 | _aAlici, Suleyman | |
| 700 | 1 | _aBerk, Veli | |
| 700 | 1 | _aDegerli, Hatice | |
| 700 | 1 | _aOner, Mehmet K | |
| 700 | 1 | _aOzturk, Cemil | |
| 700 | 1 | _aKefeli, Umut | |
| 700 | 1 | _aCamcı, Celalettin | |
| 773 | 0 |
_tOnkologie _gvol. 35 _gno. 10 _gp. 576-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000342674 _zAvailable from publisher's website |
| 999 |
_c22160080 _d22160080 |
||